JNNP: SPECT尸检确诊病例的定量分析路易体痴呆、帕金森病和阿尔茨海默病患者

2021-03-13 MedSci原创 MedSci原创

路易体痴呆(DLB)是老年人退行性痴呆的第二常见原因(尸检时为15%-25%),其与阿尔茨海默病(AD)的鉴别(老年患者为50%-60%)对于患者的预后、治疗和临床管理非常重要。目前,DLB的临床诊断

路易体痴呆(DLB)是老年人退行性痴呆的第二常见原因(尸检时为15%-25%),其与阿尔茨海默病(AD)的鉴别(老年患者为50%-60%)对于患者的预后、治疗和临床管理非常重要。目前,DLB的临床诊断是基于对痴呆患者的认知波动(注意力和警觉性有明显变化)、反复出现的视觉幻觉、快速眼动睡眠行为障碍和一个或多个帕金森病的自发性主要特征的识别尽管2005年修订的国际共识标准显示DLB的诊断敏感性增加,但临床实践中的检出率(痴呆症患者的患病率为7.2%)低于尸检时的检出率(15%–25%)。这种不理想的敏感性归因于漏诊或误诊的病例,通常为AD。
 
以往的研究表明,临床诊断为DLB的大多数患者与诊断为AD的患者相比,黑质纹状体多巴胺能神经元缺失。本研究的目的是利用活体123I-FP-CIT(脑SPECT定量分析,重新评估DLB、AD和PD患者在神经病理学诊断基础上的分化程度。
 
研究了36例患者,在生活中接受了123I-FP-CIT脑SPECT检查,随后在尸检时进行了组织病理学诊断。16名健康对照者(患者配偶)在同一时间、相同条件下进行123I-FP-CIT脑SPECT检查。大多数DLB和AD病例是在以前的出版物中报告的,比较了临床、视觉分级扫描和尸检结果。 DLB和AD病例是从痴呆记忆诊所招募的。这些帕金森病患者来自普通神经科诊所,都是迄今未确诊的帕金森病的新病例,因此他们没有晚期疾病,但都有早期运动受累。尸检证实的帕金森病病例诊断以前没有报道。除DLB、AD和PD外,还包括一组尸检时有其他诊断的患者。包括2例额颞叶痴呆、2例AD合并血管性疾病(VD)(AD+VD)、2例AD合并路易体病(LBD)(AD+LBD)、1例皮质基底细胞变性(CBD)、1例LBD+AD+VD和1例未经病理证实的患者。
 
所有脑SPECT采集均在英国伦敦大学学院核医学研究所进行。所有受试者在静脉注射约185 MBq的123I-FP-CIT后3.5-6小时,用专用的单层脑扫描仪(SME 810,Strichman Medical System,MA,USA)进行扫描。多个切片作为一组二维横轴图像依次采集。切片厚度为10毫米,连续切片之间重叠2.5毫米。切片的数量在4到10片之间变化,最常见的是6到8片。使用SME 810扫描仪中可用的滤波反投影算法进行图像重建,并由制造商专门设计,以获得每个切片的最佳分辨率和灵敏度增益。在注射123I-FP-CIT之前,受试者口服碘化钾以阻止甲状腺摄取放射性碘。重建的图像切片从NEURO-900(SME 810中提供的软件)传输到外部存储设备,然后使用内部开发的软件解释并转换为3D图像(体积)。然后,将三维图像转换成医学数字成像和通信(DICOM)格式。从二维切片堆栈到三维体的转换可能会引入一些对图像质量有影响的图像伪影。
 
在DICOM图像的基础上,分别计算两半球的尾状核结合值 (CBP)、壳核结合值(PBP)和壳核与尾状核比值(PCR)。结合值计算为[(Tg−Bk)/Bk],其中Tg表示目标区域中每个体素的平均计数,Bk表示背景参考区域中每个体素的平均计数。然后,计算每个个体的CBP、PBP和PCR的双半球平均值。不对称指数也进行了计算,但这些平均值是用于定量分析的唯一参数。在这项工作中,参考区域被定义为在去除包含基底节的大中心区域后在3D SPECT图像中可见的整个大脑。
Figure 1
 
结果显示DLB患者的CBP和PBP显著低于AD患者,PCR显著高于PD患者。图像的定性视觉分析显示,所有个体对黑质纹状体通路状态的评估准确率为88%,仅对PD、AD和DLB患者的评估准确率为96%。定量分析显示DLB与AD、DLB与PD、PD与AD二元分类的平衡准确率分别为94%、94%和100%,DLB与AD、AD与PD同时诊断的准确率为93%。AD组和HC组之间无统计学差异。
Figure 2
 
临床上明显的运动性帕金森病患者很少或不需要接受123I-FP-CIT扫描,除非对是否存在强直和/或运动迟缓或震颤的性质有疑问。在这种情况下,人们可能会发现一些不太正常甚至只有边界异常扫描的病例。对帕金森病患者进行123I-FP-CIT扫描,包括进行性核上性麻痹、多系统萎缩和CBD病例(理想情况下包括运动前PD病例)的大量临床病理学系列研究,将为123I-FP-CIT在诊断PD中的有用性提供进一步的数据和理解。
 
本研究采用双半球平均CBP、PBP和PCR。然而,运动性PD通常是不对称的(比DLB更不对称),通过集中于受影响更严重的壳核和尾状核,可以获得更高的PD检测灵敏度。本研究的是DLB和PD之间的年龄差异。PD患者平均比DLB患者年轻11岁,尸检前平均12年进行影像学检查,DLB患者平均4年。因此,摄取的差异可能不仅仅与疾病有关。
 
结论:123I-FP-CIT脑SPECT定量分析对DLB、PD和AD的鉴别诊断具有较高的准确性。本研究的主要局限性是整个SPECT影像数据库数据来源单一。然而,对所有患者的尸检诊断提供了一个优势,比许多其他研究报告在文献中对这个问题。本软件将可用于任何未来的多中心研究与尸检为基础的数据。尤其需要确认突触前多巴胺转运体显像在鉴别其他类型帕金森病方面的附加价值。
 
Oliveira FPMWalker ZWalker RWH, et al 123I-FP-CIT SPECT in dementia with Lewy bodies, Parkinson’s disease and Alzheimer’s disease: a new quantitative analysis of autopsy confirmed cases
 
 
 

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2022-01-13 feather89
  4. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-04-12 longerg
  6. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-03-15 zhouqu_8
  7. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=1818092, encodeId=983c1818092a9, content=<a href='/topic/show?id=4c9f9e777ac' target=_blank style='color:#2F92EE;'>#阿尔茨海#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97777, encryptionId=4c9f9e777ac, topicName=阿尔茨海)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=636e2500187, createdName=12498da4m32(暂无昵称), createdTime=Wed Jul 21 17:22:46 CST 2021, time=2021-07-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1817069, encodeId=50e9181e069c4, content=<a href='/topic/show?id=17b59e77626' target=_blank style='color:#2F92EE;'>#阿尔茨#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97776, encryptionId=17b59e77626, topicName=阿尔茨)], attachment=null, authenticateStatus=null, createdAvatar=https://thirdwx.qlogo.cn/mmopen/vi_32/Bnia2EtH2IvyBtniaWHPQOYAicsN3IAL1ZuPV7qyALcdCiawRJdEiafMxWTxzERQW7eeKg8HfCKCRK2CJicy073C4RJg/132, createdBy=464b2500186, createdName=ms1948154235210413, createdTime=Sun Jul 25 22:22:46 CST 2021, time=2021-07-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1728874, encodeId=21a01e2887497, content=<a href='/topic/show?id=986913980dd' target=_blank style='color:#2F92EE;'>#PE#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=13980, encryptionId=986913980dd, topicName=PE)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f06c33759375, createdName=feather89, createdTime=Thu Jan 13 15:22:46 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1933376, encodeId=e5d119333e604, content=<a href='/topic/show?id=eaf54598041' target=_blank style='color:#2F92EE;'>#定量分析#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=45980, encryptionId=eaf54598041, topicName=定量分析)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=62a7397, createdName=charl1234567, createdTime=Tue Apr 06 10:22:46 CST 2021, time=2021-04-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1754946, encodeId=00511e54946bf, content=<a href='/topic/show?id=bf6093140d4' target=_blank style='color:#2F92EE;'>#路易体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=93140, encryptionId=bf6093140d4, topicName=路易体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=576436807451, createdName=longerg, createdTime=Mon Apr 12 18:22:46 CST 2021, time=2021-04-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1434810, encodeId=f51a1434810b9, content=<a href='/topic/show?id=3b864e32794' target=_blank style='color:#2F92EE;'>#尸检#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47327, encryptionId=3b864e32794, topicName=尸检)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1470446, encodeId=6f5b14e0446fa, content=<a href='/topic/show?id=45a79e7788c' target=_blank style='color:#2F92EE;'>#阿尔茨海默#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97778, encryptionId=45a79e7788c, topicName=阿尔茨海默)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c5917090900, createdName=yhj-time, createdTime=Mon Mar 15 14:22:46 CST 2021, time=2021-03-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1048738, encodeId=9f1b1048e382f, content=老年人痴呆何药可用??, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=junJUN, createdTime=Sun Mar 14 02:22:46 CST 2021, time=2021-03-14, status=1, ipAttribution=)]
    2021-03-14 junJUN

    老年人痴呆何药可用??

    0

相关资讯

阿尔茨海默病新药“九期一”国际临床试验完成首例患者给药

中国原创治疗阿尔茨海默病新药“九期一”(甘露特钠,代号:GV-971)国际临床试验进展情况受关注。最新消息称,“九期一”国际多中心Ⅲ期临床试验近日在美国

Nat Genet:人脑蛋白质组分析与全基因组关联研究揭示阿尔茨海默病的发病机理相关的新蛋白

阿尔茨海默病(AD)影响着全球3500万人,但目前尚无有效的疾病缓解疗法。

阿尔茨海默氏病躁动症如何治疗?即将开展AXS-05的III期试验

生物制药公司Axsome Therapeutics宣布开始进行ACCORD(评估阿尔茨海默氏病躁动症的临床疗效)研究,该研究为一项随机、双盲、安慰剂对照III期试验,旨在评估AXS-05治疗阿尔茨海默

JNNP:脑脊液β-突触核蛋白可以作为阿尔茨海默病早期诊断指标

对于阿尔茨海默病(AD),脑脊液(CSF)中tau蛋白和淀粉样β肽(Aβ42)的检验已经成功地应用于当前的诊断标准和临床应用,但是无论是tau作为神经退行性变的一般标志物,还是a&

Frontiers in Neuroscience:可穿戴设备帮助AD和PD患者缓解病情

阿尔茨海默病(AD)和帕金森病(PD)都是原发性的中枢神经系统退化疾病,发病原因尚不明确。从临床症状来看,多起病隐匿而缓慢,记忆和认知功能不断恶化,且不可逆。诸多研究显示,

Science:阿尔茨海默病突触损伤的新机制,S-亚硝基化级联反应在神经病理中可能具有重要意义

研究表明,尽管Aβ具有神经毒性,然而去泛素化酶Uch-L1的S-亚硝基化也具有神经毒性,表现为突触损伤,而Uch-L1突变体(C152S)则具有神经保护作用。